Kaplan Fox Announces Investigation of Acorda Therapeutics, Inc.

NEW YORK, Nov. 15, 2017 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating Acorda Therapeutics, Inc. (Nasdaq: ACOR) on behalf of investors who purchased Acorda common stock. On November 15, 2017, Acorda announced that it has stopped enrolling new...